Skip to main content
MYUNGMOON PHARM CO.,LTD logo

MYUNGMOON PHARM CO.,LTD — Investor Relations & Filings

Ticker · 017180 ISIN · KR7017180001 KO Manufacturing
Open in API
Filings indexed 248 across all filing types
Latest filing 2026-04-30 Director's Dealing
Country KR South Korea
Listing KO 017180

About MYUNGMOON PHARM CO.,LTD

http://mmpharm.co.kr/en/main/

Myungmoon Pharm Co., Ltd. is a research-based pharmaceutical company engaged in the development, manufacturing, and commercialization of healthcare products. The company produces over 250 specialized and general medicines, holding more than 400 manufacturing licenses. Its portfolio includes both ethical (ETC) and over-the-counter (OTC) drugs, with key product areas in anesthetics, digestive agents, and antitussives. The company's operations encompass the wholesale, import, and export of its pharmaceutical products for domestic and international markets.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a Korean ‘임원ㆍ주요주주 특정증권등 소유상황보고서’ (Report on holdings/changes of specific securities by officers and major shareholders), detailing an executive’s acquisition of shares, submission dates, share counts and percentages. It is an insider share transaction report filed with the Financial Supervisory Service and Korea Exchange, matching the Director’s Dealing category.
2026-04-30 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a Korean “주식등의 대량보유상황보고서(일반)” (“Report on Large Holdings of Securities”), detailing shareholdings, changes in ownership percentages, reporting thresholds and related schedules under the Capital Markets Act. This is exactly a major shareholding notification of changes in significant share ownership levels. Therefore it maps to the Major Shareholding Notification category.
2026-04-30 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is titled “임원ㆍ주요주주 특정증권등 소유상황보고서,” detailing an executive’s share ownership, changes in holdings, acquisition dates, and ratios. It is a mandatory insider ownership report filed with the securities regulator and exchange, matching the definition of a director’s dealing (insider transaction) report.
2026-04-30 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a Korean regulatory form titled “임원ㆍ주요주주 특정증권등 소유상황보고서,” detailing an executive’s personal stock ownership and transactions (number of shares before and after, acquisition date, price, etc.), filed with the Financial Services Commission and Korea Exchange. This matches the definition for Director's Dealing (insider transactions by company directors/executives).
2026-04-30 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a mandatory regulatory disclosure titled “임원ㆍ주요주주 특정증권등 소유상황보고서” (Report on Ownership of Specific Securities by Officers and Major Shareholders). It details share counts, ownership percentages, acquisition dates and transaction prices for an executive (“임원”), matching an insider trading report. This fits the “Director’s Dealing” category.
2026-04-29 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is titled “임원ㆍ주요주주 특정증권등 소유상황보고서” and is a statutory filing to the Securities Commission and Korea Exchange detailing an executive’s share ownership, acquisition dates, quantities, and transaction prices. It is not announcing a general corporate update or a report publication but is clearly an insider share transaction report by a director/executive. This matches the definition of Director’s Dealing (DIRS).
2026-04-29 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.